Delivery Order SPE2DR25D1106-SPE2DR26FJD2U
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $4,324.70, is set to be completed by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $2,111.43. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Atropine 0.4 mg/ml vials with a ceiling value of $1,375.09. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.07 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This firm fixed price contract, with an ultimate completion date of November 28, 2025, represents a non-competitive, non-set-aside procurement executed on November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials with a ceiling value of $3,339.71 on September 24, 2025. This firm fixed-price delivery order, with completion targeted for September 25, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award was made on a non-set-aside basis through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,074.04 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atropine 1 mg/mL in vial form, with an ultimate completion date of September 18, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atropine 8 mg/20 ml vials with a ceiling value of $1,888.88. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation, reflecting the company's demonstrated...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...